CRISPR corn: Dupont’s non-transgenic drought-tolerant gene edited corn could be on sale soon

Screen Shot at PM
[R]esearchers at DuPont Pioneer. . . have published a study about a strain of corn engineered with CRISPR to be more resistant to drought. Once it receives government approval, this could soon be the first-ever CRISPR-modified crop to go on sale.

The technique outlined in theย study, published August 17 in Plant Biotechnology Journal, is particularly difficult in plants, saysย Joyce Van Eck, a professor at the Boyce Thompson Institute. . . .

. . . .

The advantages of such a crop would be felt first with farmers. . . faced with more frequent and longer droughts, Van Eck says. Consumers would also benefitโ€”more people would have access to food, and prices . . .ย would be lower.

Before DuPont can make its maize available . . .ย the plant needs to be approved by the U.S. Department of Agriculture (USDA). . .ย But itโ€™s likely that DuPontโ€™s maize wonโ€™t be subject to the same . . .ย safety evaluations as are typical GMOs. Earlier this year, the USDA told. . . researchers that itย would not regulateย [the] CRISPR-modified mushroom, and thereโ€™s reason to believe that DuPontโ€™s crop would fall into the same regulatory gap.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post:ย CRISPR-Modified Corn May Soon Be Ready For Market

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellisonโ€™s half-billion-dollar Hawaii greenhouse dream goes bust
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-May-8-2026-01_41_33-PM-3
Viewpoint: Surge of climate misinformation traced to right wing and anti-wind activistsย 
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTCโ€”a great idea. Hereโ€™s why itโ€™s unlikely to happen
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.